Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Current Deferred Tax Assets (2020 - 2023)

Intelligent Bio Solutions has reported Current Deferred Tax Assets over the past 3 years, most recently at $34100.0 for Q2 2023.

For Q2 2023, Current Deferred Tax Assets changed N/A year-over-year to $34100.0; the TTM value through Jun 2023 reached $34100.0, changed N/A, while the annual FY2023 figure was $34100.0, N/A changed from the prior year.
Current Deferred Tax Assets for Q2 2023 was $34100.0 at Intelligent Bio Solutions, down from $300000.0 in the prior quarter.
Over five years, Current Deferred Tax Assets peaked at $1.9 million in Q2 2020 and troughed at $34100.0 in Q2 2023.
A 3-year average of $732571.0 and a median of $300000.0 in 2022 define the central range for Current Deferred Tax Assets.